Gastrointestinal bleeding (GIB) poses significant diagnostic and therapeutic challenges to healthcare professionals. Understanding the diverse etiologies and the complex management strategies is crucial for optimal patient care.
Initial evaluation of GIB involves a thorough history and physical examination. Laboratory tests, including complete blood count, coagulation profile, and liver function tests, provide essential information about the severity and potential causes of bleeding. Endoscopy remains the gold standard diagnostic tool for most causes of GIB. Upper endoscopy is typically performed for upper GIB, while colonoscopy is the first-line investigation for lower GIB. Capsule endoscopy and balloon-assisted enteroscopy are valuable for diagnosing small bowel bleeding.
Treatment of GIB should be individualized, depending on the cause, location, and severity of bleeding. Hemodynamic stabilization is the primary goal, often necessitating intravenous fluids and blood transfusions. Endoscopic therapy, including injection, thermal coagulation, and mechanical methods, is the mainstay of treatment for most causes of GIB. Non-variceal bleeding may require proton pump inhibitor therapy, while variceal bleeding often necessitates vasoactive drugs and band ligation. Surgery or interventional radiology may be required for refractory cases.
Risk stratification tools, such as the Glasgow-Blatchford and Rockall scores, help predict the need for intervention and the risk of rebleeding or mortality in GIB. These tools guide decision-making regarding hospital admission, level of care, and timing of endoscopy.
Managing GIB requires a systematic approach, encompassing prompt diagnosis, appropriate treatment, and accurate risk stratification. Continuous advancements in endoscopic techniques and therapeutic strategies promise to further improve outcomes in GIB.
1.
New drug combination shows good results in patients with HPV-negative head and neck cancer
2.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
3.
Asian Women With Breast Cancer Outlive White Peers
4.
What Comes After Cancer?
5.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
1.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
2.
Spatial Transcriptomics in Oncology: Transforming Tumor Biology and Precision Medicine
3.
Inside Oncology Trials: From Protocol to Progress in Cancer Research and Care
4.
Endurance Training in Hematologic Disease: Current Perspectives and Clinical Implications
5.
Cowden Syndrome and Cancer: Understanding the Risk Factors
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Understanding Common Causes of Abnormal Blood Counts
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
5.
Diagnosis and Management in Hematology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation